Found 2 bookmarks
Custom sorting
emClinical & Translational Immunology/em | ASI Journal | Wiley Online Library
emClinical & Translational Immunology/em | ASI Journal | Wiley Online Library
“In conclusion, our findings demonstrate that immunomodulatory changes in both myeloid and lymphoid cells can persist for up to 17 months following COVID-19, even in individuals who experienced only MILD illness.”m
#Immune system#Post-Acute Conditions#Myeloid cells#Lymphoid cells#immunomodulatory changes#Immune Deficiency#immune dysregulation#risks
·onlinelibrary.wiley.com·
emClinical & Translational Immunology/em | ASI Journal | Wiley Online Library
COVID-19 may put patients at risk for other infections for at least 1 year | CIDRAP
COVID-19 may put patients at risk for other infections for at least 1 year | CIDRAP
“a positive test for COVID-19 is associated with increased rates of diagnosis of various non–SARS-CoV-2 infections in the 12 months following an acute SARS-CoV-2 infection, even if the initial infection is mild to moderate.”
#Immune system#Post-Acute Conditions#Immune dysregulation#risks#Immune Deficiency#increase in other infections
·cidrap.umn.edu·
COVID-19 may put patients at risk for other infections for at least 1 year | CIDRAP